Eesti Nukleaarmeditsiini Selts

Active Registry code 80209530 MTÜ Tallinn Registered 23 Aug 2004
Compare

Eesti Nukleaarmeditsiini Selts is a MTÜ based in Tallinn, registry code 80209530, status: active. Main activity: Research and experimental development on natural sciences and engineering. Its annual report for 2025 shows revenue of €0 and 0 employees.

Turnover
—
State taxes
1 360 €
Labour taxes
84 €
Employees
—

Q2 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Scientific research and development · EMTAK 72

  • Revenue · 2025 0 €
    industry median 0 € · companies in the industry: 1 073

Taxes and turnover

Q3 2022 – Q2 2026
State taxes, € Q2 2026: 1 360 € · +1 273.7% vs Q2 2024
05001 0001 500Q3 2022 Company: 20 €Q3·22Q2 2024 Company: 99 €Q2·24Q2 2026 Company: 1 360 €Q2·2605001 0001 500Q3 2022 Company: 20 €Q3·22Q2 2024 Company: 99 €Q2 2026 Company: 1 360 €Q2·26
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q2 2026 — 1 360 84 —
Q2 2024 — 99 62 —
Q3 2022 — 20 12 —

Financials by year

2016 – 2025
Revenue, € 2025: 0 € · industry median 0 € · above 5% of the industry
0501001502016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 0 € Industry median: 0 €20192020 Company: 0 € Industry median: 150 €20202021 Company: 0 € Industry median: 0 €20212022 Company: 0 € Industry median: 103 €20222023 Company: 0 € Industry median: 76 €20232024 Company: 0 € Industry median: 0 €20242025 Company: 0 € Industry median: 0 €20250501001502018 Company: — Industry median: —2019 Company: 0 € Industry median: 0 €20192020 Company: 0 € Industry median: 150 €2021 Company: 0 € Industry median: 0 €20212022 Company: 0 € Industry median: 103 €2023 Company: 0 € Industry median: 76 €20232024 Company: 0 € Industry median: 0 €2025 Company: 0 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 822 € · −79.5% vs 2024 · industry median 0 € · above 63% of the industry
-4 000-2 00002 0004 0006 0002016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: -2 515 € Industry median: 3 €20192020 Company: 320 € Industry median: 28 €20202021 Company: -189 € Industry median: 1 €20212022 Company: -541 € Industry median: 0 €20222023 Company: -639 € Industry median: 0 €20232024 Company: 4 011 € Industry median: 0 €20242025 Company: 822 € Industry median: 0 €2025-4 000-2 00002 0004 0006 0002018 Company: — Industry median: —2019 Company: -2 515 € Industry median: 3 €20192020 Company: 320 € Industry median: 28 €2021 Company: -189 € Industry median: 1 €20212022 Company: -541 € Industry median: 0 €2023 Company: -639 € Industry median: 0 €20232024 Company: 4 011 € Industry median: 0 €2025 Company: 822 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 9 590 € · +9.4% vs 2024
02 0004 0006 0008 00010 0002016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 4 806 €20192020 Company: 5 126 €20202021 Company: 4 937 €20212022 Company: 4 396 €20222023 Company: 4 757 €20232024 Company: 8 768 €20242025 Company: 9 590 €202502 0004 0006 0008 00010 0002018 Company: —2019 Company: 4 806 €20192020 Company: 5 126 €2021 Company: 4 937 €20212022 Company: 4 396 €2023 Company: 4 757 €20232024 Company: 8 768 €2025 Company: 9 590 €2025
Equity, € 2025: 8 590 € · +10.6% vs 2024
02 0004 0006 0008 00010 0002016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 4 806 €20192020 Company: 5 126 €20202021 Company: 4 937 €20212022 Company: 4 396 €20222023 Company: 3 757 €20232024 Company: 7 768 €20242025 Company: 8 590 €202502 0004 0006 0008 00010 0002018 Company: —2019 Company: 4 806 €20192020 Company: 5 126 €2021 Company: 4 937 €20212022 Company: 4 396 €2023 Company: 3 757 €20232024 Company: 7 768 €2025 Company: 8 590 €2025
Employees 2025: 0 · industry median 1 · above 2% of the industry
0.00.51.01.52.02016 Company: 0 Industry median: —20162017 Company: 0 Industry median: —20172018 Company: 0 Industry median: 120182019 Company: 0 Industry median: 120192020 Company: 0 Industry median: 120202021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 120242025 Company: 0 Industry median: 120250.00.51.01.52.02018 Company: 0 Industry median: 12019 Company: 0 Industry median: 120192020 Company: 0 Industry median: 12021 Company: 0 Industry median: 120212022 Company: 0 Industry median: 22023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 12025 Company: 0 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 0 822 0 9 590 8 590 0
2024 0 4 011 0 8 768 7 768 0
2023 0 -639 0 4 757 3 757 0
2022 0 -541 0 4 396 4 396 0
2021 0 -189 0 4 937 4 937 0
2020 0 320 0 5 126 5 126 0
2019 0 -2 515 2 776 4 806 4 806 0
2018 — — — — — 0
2017 — — — — — 0
2016 — — — — — 0
2015 — — — — — 0
2014 — — — — — 0
2013 — — — — — 0
2012 — — — — — 0
2011 — — — — — 0
2010 — — — — — 0
2009 — — — — — 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin
31.9 %
Net profit / revenue
Return on equity (ROE)
9.6 %
Net profit / equity
Return on assets (ROA)
8.6 %
Net profit / assets
Equity ratio
89.6 %
Equity / assets
Debt ratio
10.4 %
Liabilities / assets
Current ratio
9.59
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 26 Jun 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 3 Jun 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 17 May 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 18 Jun 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 27 Jun 2022 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 7 Jun 2021 Company’s own e-Äriregister
2019 1 Jan 2019 – 31 Dec 2019 26 May 2020 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the non-profit association in all transactions.

Owners

No owner information.

Beneficial owners

  • Ilona Muoni
    Management board member(s) · since 9 May 2023
  • Tiina Kärner
    Management board member(s) · since 11 Aug 2019
  • Anne Poksi
    Management board member(s) · since 28 Oct 2018

Founders and other persons

No other persons.

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 72101Research and experimental development on natural sciences and engineering Main
Rulings
Number, date Title Deadline State Document
M 10082233 / 11
12 May 2025
Amendment under Code of Civil Procedure § 595¹ (1) In force
12 May 2025
PDF
M 10082233 / 10
3 Jun 2024
Amendment entry In force
3 Jun 2024
PDF
M 10082233 / M3
29 May 2024
Procedural ruling 5 Jun 2024 Deficiencies eliminated
3 Jun 2024
PDF
M 10082233 / 9
9 May 2023
Amendment entry In force
9 May 2023
PDF
M 10082233 / M2
24 Apr 2023
Ruling to eliminate deficiencies 9 May 2023 Deficiencies eliminated
9 May 2023
PDF
M 10082233 / 8
1 Feb 2023
Amendment entry In force
1 Feb 2023
PDF
M 10082233 / 7
25 Jun 2019
Amendment entry In force
25 Jun 2019
PDF
M 10082233 / 6
8 Nov 2017
Amendment entry In force
8 Nov 2017
PDF
M 10082233 / 5
14 Jan 2016
Amendment entry In force
14 Jan 2016
PDF
M 10082233 / 4
17 Jan 2013
Amendment entry In force
17 Jan 2013
PDF
M 10082233 / 3
1 Jul 2010
Amendment entry In force
1 Jul 2010
PDF
M 10082233 / M1
15 Jun 2010
Ruling to eliminate deficiencies 9 Jul 2010 Deficiencies eliminated
29 Jun 2010
PDF
M 82233 / 2
5 Feb 2008
Amendment entry In force
5 Feb 2008
PDF
M 82233
19 Aug 2004
First entry In force PDF

Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data